Zobrazeno 1 - 10
of 104
pro vyhledávání: '"K. Tarrant"'
Autor:
Jaime M. Brozowski, Roman G. Timoshchenko, D. Stephen Serafin, Brittney Allyn, Jessica Koontz, Emily M. Rabjohns, Rishi R. Rampersad, Yinshi Ren, Amanda M. Eudy, Taylor F. Harris, David Abraham, Daniel Mattox, Clinton T. Rubin, Matthew J. Hilton, Janet Rubin, Nancy L. Allbritton, Matthew J. Billard, Teresa K. Tarrant
Publikováno v:
Stem Cell Research & Therapy, Vol 13, Iss 1, Pp 1-15 (2022)
Abstract Background The bone marrow niche supports hematopoietic cell development through intimate contact with multipotent stromal mesenchymal stem cells; however, the intracellular signaling, function, and regulation of such supportive niche cells
Externí odkaz:
https://doaj.org/article/124f702e78d146ed89416332f38c7248
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
G-protein coupled receptor kinases (GRKs) participate in the regulation of chemokine receptors by mediating receptor desensitization. They can be recruited to agonist-activated G-protein coupled receptors (GPCRs) and phosphorylate their intracellular
Externí odkaz:
https://doaj.org/article/fe26a5112ab246a8998e5b09101fe4e3
Autor:
Emily M. Rabjohns, Rishi R. Rampersad, Arin Ghosh, Katlyn Hurst, Amanda M. Eudy, Jaime M. Brozowski, Hyun Ho Lee, Yinshi Ren, Anthony Mirando, Justin Gladman, Jessica L. Bowser, Kathryn Berg, Sachin Wani, Stuart H. Ralston, Matthew J. Hilton, Teresa K. Tarrant
Publikováno v:
Cells, Vol 12, Iss 7, p 981 (2023)
Paget’s Disease of Bone (PDB) is a metabolic bone disease that is characterized by dysregulated osteoclast function leading to focal abnormalities of bone remodeling. It can lead to pain, fracture, and bone deformity. G protein-coupled receptor kin
Externí odkaz:
https://doaj.org/article/d4ebb64765294ed991aa8881105b3d2b
Autor:
D. C. Dale, L. Alsina, A. Azar, R. Badolato, Y. Bertrand, A. Deya, K. E. Dickerson, N. Ezra, H. Hasle, H. J. Kang, S. Kiani-Alikhan, T. Kuijpers, A. Kulagin, D. Langguth, C. Levin, O. Neth, J. Peake, C. E. Rutten, A. Shcherbina, T. K. Tarrant, M. G. Vossen, C. A. Wysocki, A. Belschner, D. Cadavid, Y. Hu, H. Jiang, R. MacLeod, W. Tang, M. Tillinger, J. Donadieu
Publikováno v:
HemaSphere, Vol 6, Pp 1814-1815 (2022)
Externí odkaz:
https://doaj.org/article/2d8f9dddd1444c099d979b8d305847f6
Publikováno v:
Current Allergy and Asthma Reports. 22:141-150
Autor:
William C. Zamboni, Charles M. Perou, Andrew C. Dudley, Arlin B. Rogers, Teresa K. Tarrant, C. Ryan Miller, Nana Nikolaishvili-Feinberg, Stephanie Cohen, Bentley R. Midkiff, Jamie L. Jordan, Alain Valdivia, Mark Ross, Charlene M. Santos, David B. Darr, Gina Song
Supplementary Fig. S3. Profiling of collagen in basal-like C3-TAg model and claudin-low T11 model at baseline and at 96 h after administration of PLD or NL-doxo at 6 mg/kg I.V. x 1 via tail vein
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc71154b91cc2042f3442bd51e4b8470
https://doi.org/10.1158/1078-0432.22456287.v1
https://doi.org/10.1158/1078-0432.22456287.v1
Autor:
William C. Zamboni, Charles M. Perou, Andrew C. Dudley, Arlin B. Rogers, Teresa K. Tarrant, C. Ryan Miller, Nana Nikolaishvili-Feinberg, Stephanie Cohen, Bentley R. Midkiff, Jamie L. Jordan, Alain Valdivia, Mark Ross, Charlene M. Santos, David B. Darr, Gina Song
Supplementary Data. Table S1. Product information from FormuMax Scientific, Inc. Table S2. Doxorubicin AUC0-96h in plasma, tissues, and tumor in the C3-TAg model and the T11 model after PLD or NL-doxo administration at 6 mg/kg I.V. x 1 via tail vein
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d5eef07a6263cca0d09627ab18668a7
https://doi.org/10.1158/1078-0432.22456296.v1
https://doi.org/10.1158/1078-0432.22456296.v1
Autor:
William C. Zamboni, Charles M. Perou, Andrew C. Dudley, Arlin B. Rogers, Teresa K. Tarrant, C. Ryan Miller, Nana Nikolaishvili-Feinberg, Stephanie Cohen, Bentley R. Midkiff, Jamie L. Jordan, Alain Valdivia, Mark Ross, Charlene M. Santos, David B. Darr, Gina Song
Purpose: Tumor cells are surrounded by a complex microenvironment. The purpose of our study was to evaluate the role of heterogeneity of the tumor microenvironment in the variability of nanoparticle (NP) delivery and efficacy.Experimental Designs:C3(
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ccbc13d16ad8b3f6c8192576b91d968a
https://doi.org/10.1158/1078-0432.c.6523266.v1
https://doi.org/10.1158/1078-0432.c.6523266.v1
Autor:
Elizabeth J. Malcolm, Zachary Brandon, Lauren E. Wilson, John Paul Shoup, Heather A. King, Allison Lewinski, Melissa A. Greiner, Shauna Malone, Julie Miller, Robert T. Keenan, Teresa K. Tarrant, Donna Phinney, Alex Cho, Hayden B. Bosworth, Kevin Shah
Publikováno v:
JCR: Journal of Clinical Rheumatology. 28:147-154
Publikováno v:
Expert Opinion on Orphan Drugs. 9:257-264